SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-22-000013
Filing Date
2022-11-09
Accepted
2022-11-09 16:19:14
Documents
111
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20220930.htm   iXBRL 10-Q 2107819
2 EX-31.1 pgen-20220930xexx311.htm EX-31.1 10481
3 EX-31.2 pgen-20220930xexx312.htm EX-31.2 10144
4 EX-32.1 pgen-20220930xexx321.htm EX-32.1 5911
5 EX-32.2 pgen-20220930xexx322.htm EX-32.2 5988
  Complete submission text file 0001356090-22-000013.txt   10719294

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20220930.xsd EX-101.SCH 68834
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20220930_cal.xml EX-101.CAL 121841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20220930_def.xml EX-101.DEF 489352
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20220930_lab.xml EX-101.LAB 836510
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20220930_pre.xml EX-101.PRE 676897
105 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20220930_htm.xml XML 1830938
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 221372921
SIC: 2834 Pharmaceutical Preparations